End-of-day quote
Shanghai S.E.
06:00:00 2024-07-11 pm EDT
|
5-day change
|
1st Jan Change
|
12.9
CNY
|
+0.23%
|
|
0.00%
|
-24.21%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
23,252
|
22,302
|
23,778
|
15,988
|
25,427
|
19,272
|
-
|
-
|
Enterprise Value (EV)
1 |
29,451
|
23,121
|
23,086
|
14,968
|
23,635
|
16,566
|
15,751
|
14,843
|
P/E ratio
|
23.4
x
|
19.7
x
|
10.1
x
|
-63.3
x
|
23.6
x
|
15.7
x
|
13.5
x
|
12.7
x
|
Yield
|
2.14%
|
2.23%
|
2.08%
|
3.07%
|
1.94%
|
2.7%
|
2.84%
|
3.2%
|
Capitalization / Revenue
|
1.22
x
|
1.64
x
|
2.99
x
|
1.86
x
|
2.93
x
|
2.12
x
|
1.94
x
|
1.89
x
|
EV / Revenue
|
1.55
x
|
1.7
x
|
2.9
x
|
1.74
x
|
2.72
x
|
1.82
x
|
1.58
x
|
1.45
x
|
EV / EBITDA
|
16.7
x
|
11.2
x
|
7.32
x
|
50.8
x
|
14.2
x
|
7.88
x
|
6.75
x
|
6.32
x
|
EV / FCF
|
-
|
16.6
x
|
-
|
-
|
-
|
13.8
x
|
15.5
x
|
13.1
x
|
FCF Yield
|
-
|
6.01%
|
-
|
-
|
-
|
7.24%
|
6.45%
|
7.63%
|
Price to Book
|
2.1
x
|
1.87
x
|
1.83
x
|
1.3
x
|
2.06
x
|
1.46
x
|
1.35
x
|
1.27
x
|
Nbr of stocks (in thousands)
|
1,507,920
|
1,507,920
|
1,500,163
|
1,485,873
|
1,493,950
|
1,493,950
|
-
|
-
|
Reference price
2 |
15.42
|
14.79
|
15.85
|
10.76
|
17.02
|
12.90
|
12.90
|
12.90
|
Announcement Date
|
4/25/20
|
4/23/21
|
3/30/22
|
3/27/23
|
4/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,998
|
13,576
|
7,952
|
8,593
|
8,674
|
9,080
|
9,951
|
10,203
|
EBITDA
1 |
1,762
|
2,062
|
3,153
|
294.6
|
1,663
|
2,104
|
2,334
|
2,347
|
EBIT
1 |
1,338
|
1,472
|
2,733
|
-153
|
1,228
|
1,413
|
1,616
|
1,704
|
Operating Margin
|
7.04%
|
10.85%
|
34.37%
|
-1.78%
|
14.16%
|
15.56%
|
16.24%
|
16.7%
|
Earnings before Tax (EBT)
1 |
1,331
|
1,457
|
2,724
|
-160.5
|
1,221
|
1,490
|
1,704
|
1,814
|
Net income
1 |
1,001
|
1,126
|
2,359
|
-256.5
|
1,071
|
1,247
|
1,441
|
1,516
|
Net margin
|
5.27%
|
8.29%
|
29.66%
|
-2.99%
|
12.35%
|
13.73%
|
14.48%
|
14.86%
|
EPS
2 |
0.6600
|
0.7500
|
1.570
|
-0.1700
|
0.7200
|
0.8207
|
0.9556
|
1.013
|
Free Cash Flow
1 |
-
|
1,389
|
-
|
-
|
-
|
1,199
|
1,016
|
1,132
|
FCF margin
|
-
|
10.23%
|
-
|
-
|
-
|
13.2%
|
10.21%
|
11.09%
|
FCF Conversion (EBITDA)
|
-
|
67.33%
|
-
|
-
|
-
|
56.98%
|
43.55%
|
48.24%
|
FCF Conversion (Net income)
|
-
|
123.34%
|
-
|
-
|
-
|
96.13%
|
70.51%
|
74.66%
|
Dividend per Share
2 |
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3488
|
0.3666
|
0.4134
|
Announcement Date
|
4/25/20
|
4/23/21
|
3/30/22
|
3/27/23
|
4/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
2,103
|
2,049
|
2,541
|
2,471
|
2,896
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.5800
|
-0.3719
|
0.1000
|
0.0500
|
0.0500
|
0.1774
|
0.2900
|
0.2200
|
0.0300
|
0.1976
|
0.2200
|
0.2300
|
0.3300
|
0.3000
|
0.2800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/22
|
4/25/22
|
8/19/22
|
10/25/22
|
3/27/23
|
4/24/23
|
8/25/23
|
10/27/23
|
4/15/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,199
|
818
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
692
|
1,020
|
1,792
|
2,706
|
3,521
|
4,429
|
Leverage (Debt/EBITDA)
|
3.518
x
|
0.3968
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
1,389
|
-
|
-
|
-
|
1,199
|
1,016
|
1,132
|
ROE (net income / shareholders' equity)
|
9.28%
|
9.76%
|
18.4%
|
-2.04%
|
8.75%
|
9.64%
|
10.3%
|
10.1%
|
ROA (Net income/ Total Assets)
|
4.07%
|
5.56%
|
14.3%
|
-
|
7.12%
|
6.65%
|
7.39%
|
7.47%
|
Assets
1 |
24,593
|
20,253
|
16,518
|
-
|
15,049
|
18,751
|
19,511
|
20,307
|
Book Value Per Share
2 |
7.360
|
7.910
|
8.660
|
8.270
|
8.250
|
8.840
|
9.520
|
10.20
|
Cash Flow per Share
2 |
1.110
|
1.180
|
1.870
|
1.520
|
1.720
|
1.100
|
1.090
|
1.440
|
Capex
1 |
729
|
403
|
503
|
402
|
668
|
506
|
416
|
413
|
Capex / Sales
|
3.84%
|
2.96%
|
6.32%
|
4.68%
|
7.7%
|
5.57%
|
4.18%
|
4.04%
|
Announcement Date
|
4/25/20
|
4/23/21
|
3/30/22
|
3/27/23
|
4/15/24
|
-
|
-
|
-
|
Last Close Price
12.9
CNY Average target price
16.17
CNY Spread / Average Target +25.36% Consensus |
1st Jan change
|
Capi.
|
---|
| -24.21% | 2.66B | | +12.92% | 4.95B | | -32.29% | 3.6B | | -4.28% | 3.03B | | -8.82% | 2.34B | | +39.33% | 1.85B | | +40.81% | 1.45B | | -14.27% | 1.41B | | +41.90% | 1.38B | | -25.47% | 1.31B |
Alternative Medicine
|